Extensive replicative capacity of human central memory T cells - PubMed (original) (raw)
Extensive replicative capacity of human central memory T cells
Marcela V Maus et al. J Immunol. 2004.
Abstract
To characterize the replicative capacity of human central memory (T(CM)) CD4 T cells, we have developed a defined culture system optimized for the ex vivo expansion of Ag-specific CD4(+) T cells. Artificial APCs (aAPCs) consisting of magnetic beads coated with Abs to HLA class II and a costimulatory Ab to CD28 were prepared; peptide-charged HLA class II tetramers were then loaded on the beads to provide Ag specificity. Influenza-specific DR*0401 CD4 T(CM) were isolated from the peripheral blood of normal donors by flow cytometry. Peptide-loaded aAPC were not sufficient to induce resting CD4 T(CM) to proliferate. In contrast, we found that the beads efficiently promoted the growth of previously activated CD4 T(CM) cells, yielding cultures with >80% Ag-specific CD4 cells after two stimulations. Further stimulation with peptide-loaded aAPC increased purity to >99% Ag-specific T cells. After in vitro culture for 3-12 wk, the flu-specific CD4 T(CM) had surface markers that were generally consistent with an effector phenotype described for CD8 T cells, except for the maintenance of CD28 expression. The T(CM) were capable of 20-40 mean population doublings in vitro, and the expanded cells produced IFN-gamma, IL-2, and TNF-alpha in response to Ag, and a subset of cells also secreted IL-4 with PMA/ionomycin treatment. In conclusion, aAPCs expand T(CM) that have extensive replicative capacity, and have potential applications in adoptive immunotherapy as well as for studying the biology of human MHC class II-restricted T cells.
Similar articles
- 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.
Zhang H, Snyder KM, Suhoski MM, Maus MV, Kapoor V, June CH, Mackall CL. Zhang H, et al. J Immunol. 2007 Oct 1;179(7):4910-8. doi: 10.4049/jimmunol.179.7.4910. J Immunol. 2007. PMID: 17878391 Free PMC article. - Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4(+) T cells.
Garnier A, Hamieh M, Drouet A, Leprince J, Vivien D, Frébourg T, Le Mauff B, Latouche JB, Toutirais O. Garnier A, et al. Immunol Cell Biol. 2016 Aug;94(7):662-72. doi: 10.1038/icb.2016.25. Epub 2016 Feb 29. Immunol Cell Biol. 2016. PMID: 26924643 - A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy.
Alvarez-Fernández C, Escribà-Garcia L, Vidal S, Sierra J, Briones J. Alvarez-Fernández C, et al. J Transl Med. 2016 Jul 19;14(1):214. doi: 10.1186/s12967-016-0973-y. J Transl Med. 2016. PMID: 27435312 Free PMC article. - A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytes.
Thomas AK, Maus MV, Shalaby WS, June CH, Riley JL. Thomas AK, et al. Clin Immunol. 2002 Dec;105(3):259-72. doi: 10.1006/clim.2002.5277. Clin Immunol. 2002. PMID: 12498807 - Clonal analysis of functionally distinct human CD4+ T cell subsets.
Rotteveel FT, Kokkelink I, van Lier RA, Kuenen B, Meager A, Miedema F, Lucas CJ. Rotteveel FT, et al. J Exp Med. 1988 Nov 1;168(5):1659-73. doi: 10.1084/jem.168.5.1659. J Exp Med. 1988. PMID: 2903211 Free PMC article.
Cited by
- Adoptive T cell therapy of solid cancers.
Knutson KL, Wagner W, Disis ML. Knutson KL, et al. Cancer Immunol Immunother. 2006 Jan;55(1):96-103. doi: 10.1007/s00262-005-0706-1. Epub 2005 Oct 27. Cancer Immunol Immunother. 2006. PMID: 15891880 Free PMC article. Review. - Chimeric antigen receptor therapy for cancer.
Barrett DM, Singh N, Porter DL, Grupp SA, June CH. Barrett DM, et al. Annu Rev Med. 2014;65:333-47. doi: 10.1146/annurev-med-060512-150254. Epub 2013 Nov 20. Annu Rev Med. 2014. PMID: 24274181 Free PMC article. Review. - Interleukin-7 signalling is sufficient to phenotypically and functionally prime human CD4 naive T cells.
Managlia EZ, Landay A, Al-Harthi L. Managlia EZ, et al. Immunology. 2005 Mar;114(3):322-35. doi: 10.1111/j.1365-2567.2004.02089.x. Immunology. 2005. PMID: 15720434 Free PMC article. - Immunologic consequences of chemotherapy for acute myeloid leukemia.
Reilly A, Kersun LS, Luning Prak E, Boyer J, McDonald K, Jawad AF, Sullivan KE. Reilly A, et al. J Pediatr Hematol Oncol. 2013 Jan;35(1):46-53. doi: 10.1097/MPH.0b013e318266c0c8. J Pediatr Hematol Oncol. 2013. PMID: 23018569 Free PMC article. - Trafficking and persistence of alloantigen-specific chimeric antigen receptor regulatory T cells in Cynomolgus macaque.
Ellis GI, Coker KE, Winn DW, Deng MZ, Shukla D, Bhoj V, Milone MC, Wang W, Liu C, Naji A, Duran-Struuck R, Riley JL. Ellis GI, et al. Cell Rep Med. 2022 May 17;3(5):100614. doi: 10.1016/j.xcrm.2022.100614. Epub 2022 May 11. Cell Rep Med. 2022. PMID: 35551746 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous